ID: ALA4580389

Max Phase: Preclinical

Molecular Formula: C9H14N2

Molecular Weight: 150.22

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CCC1NCCn2cccc21

Standard InChI:  InChI=1S/C9H14N2/c1-2-8-9-4-3-6-11(9)7-5-10-8/h3-4,6,8,10H,2,5,7H2,1H3

Standard InChI Key:  KXOHPRHOYYETRK-UHFFFAOYSA-N

Associated Targets(non-human)

pyrC Dihydroorotase (41 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 150.22Molecular Weight (Monoisotopic): 150.1157AlogP: 1.54#Rotatable Bonds: 1
Polar Surface Area: 16.96Molecular Species: BASEHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 8.52CX LogP: 1.52CX LogD: 0.37
Aromatic Rings: 1Heavy Atoms: 11QED Weighted: 0.64Np Likeness Score: -0.49

References

1. Rice AJ, Lei H, Santarsiero BD, Lee H, Johnson ME..  (2016)  Ca-asp bound X-ray structure and inhibition of Bacillus anthracis dihydroorotase (DHOase).,  24  (19): [PMID:27499369] [10.1016/j.bmc.2016.07.055]

Source